Incyte Corp (NASDAQ:INCY)

73.43
Delayed Data
As of 4:00pm ET
 +0.45 / +0.62%
Today’s Change
60.23
Today|||52-Week Range
140.11
-22.47%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close72.98
Today’s open73.38
Day’s range72.78 - 74.30
Volume1,914,718
Average volume (3 months)2,355,713
Market cap$14.2B
Data as of 4:00pm ET, 06/20/2018

Growth & Valuation

Earnings growth (last year)-383.33%
Earnings growth (this year)+117.88%
Earnings growth (next 5 years)+63.70%
Revenue growth (last year)+38.93%
P/E ratioNM
Price/Sales12.61
Price/Book8.71

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.25-0.29%
ALXNAlexion Pharmaceutic...+2.61+2.14%
BAXBaxter International...-0.84-1.13%
MYLMylan NV+0.14+0.36%
Data as of 4:02pm ET, 06/20/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.17
Annual revenue (last year)$1.5B
Annual profit (last year)-$313.1M
Net profit margin-20.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts